4//SEC Filing
Halstead Michael 4
Accession 0000950170-25-032586
CIK 0001567514other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:01 PM ET
Size
8.7 KB
Accession
0000950170-25-032586
Insider Transaction Report
Form 4
Halstead Michael
SVP and General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-01−12,239→ 24,478 total→ Common Stock (12,239 underlying) - Tax Payment
Common Stock
2025-03-01$128.20/sh−6,261$802,660→ 11,304 total - Exercise/Conversion
Common Stock
2025-03-01+12,239→ 17,565 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]On March 1, 2024, the reporting person was granted 36,717 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001521548
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:01 PM ET
- Size
- 8.7 KB